Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Pro Medicus Limited (PME.AX)
AUD194.84
-4.14 (-2.08%)
AU ASX Healthcare Medical - Healthcare Information Services
Address
450 Swan Street 3121
Richmond, VIC, AU
Richmond, VIC, AU
CEO
Sam Aaron Hupert
Website
promed.com.au
IPO
2000-10-09
ISIN AU000000PME8
Also trades on
Australian Securities Exchange · PME.AX (AUD)
Other OTC · PMCUF (USD)
Description
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
AUD194.84
-4.14 (-2.08%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
337.7K
Beta
0.59
Float Shares
53.01M
Free Float %
50.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.60% | +3.26% | -1.59% | +1.74% | -50.38% | -40.12% | -53.08% | +122.85% | +186.84% | +2,666.95% | +11,400.87% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
194.84
DCF (Unlevered)
100.01
-48.7%
DCF (Levered)
94.31
-51.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
75% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 9 | +1 |
| Hold | 3 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
60.81
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
7 / 10
Strong MOAT
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
★ Strong MOAT
-
Revenue growth Medical - Healthcare Information Services: +14.2%+31.9% ★ Q4'25: +68.4% (vs Q4'23)
-
EPS growth Medical - Healthcare Information Services: +43.1%+39.2% Q4'25: +368.6% (vs Q4'23)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%+45.3% Q4'25: +55.4% (vs Q4'23)
-
EBIT margin Medical - Healthcare Information Services: +8.8%+74.0% ★ Q4'25: +72.7% (vs Q4'23)
-
ROIC Medical - Healthcare Information Services: +5.2%+222.3% ★ Q4'25: +150.4% (vs Q4'23)
-
Share dilution Medical - Healthcare Information Services: -0.1%+0.0% ★ Q4'25: -0.1% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×0.01× ★ Q4'25: 0.01× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Jun 2001 actual |
Jun 2002 actual |
Jun 2003 actual |
Jun 2004 actual |
Jun 2005 actual |
Jun 2006 actual |
Jun 2007 actual |
Jun 2008 actual |
Jun 2009 actual |
Jun 2010 actual |
Jun 2015 actual |
Jun 2016 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 14 Rev. Ana. 10 EPS Ana. |
Jun 2027 14 Rev. Ana. 11 EPS Ana. |
Jun 2028 14 Rev. Ana. 10 EPS Ana. |
Jun 2029 10 Rev. Ana. 4 EPS Ana. |
Jun 2030 7 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
9.99M
est: 11.67M (-14.4%)
|
10.16M
est: 12.09M (-16.0%)
|
9.10M
est: 10.37M (-12.2%)
|
7.90M
est: 8.06M (-1.9%)
|
10.28M
est: 11.68M (-12.0%)
|
11.30M
est: 11.67M (-3.2%)
|
12.54M
est: 12.55M (-0.1%)
|
9.16M
est: 15.48M (-40.8%)
|
9.94M
est: 20.91M (-52.5%)
|
19.20M
est: 19.69M (-2.5%)
|
17.49M
est: 17.50M (-0.1%)
|
27.52M
est: 27.35M (+0.6%)
|
31.60M
est: 32.10M (-1.6%)
|
35.92M
est: 37.35M (-3.8%)
|
50.11M
est: 48.75M (+2.8%)
|
56.82M
est: 59.91M (-5.1%)
|
67.88M
est: 70.01M (-3.0%)
|
93.46M
est: 94.13M (-0.7%)
|
124.90M
est: 121.32M (+2.9%)
|
161.43M
est: 161.43M (+0.0%)
|
212.91M
est: 212.54M (+0.2%)
|
260.60M
250.64M – 276.02M
+22.6% YoY
|
336.45M
315.75M – 356.44M
+29.1% YoY
|
417.60M
415.26M – 419.94M
+24.1% YoY
|
522.68M
495.88M – 553.67M
+25.2% YoY
|
516.80M
490.30M – 547.45M
-1.1% YoY
|
| EBITDA |
6.27M
est: 8.71M (-28.0%)
|
6.89M
est: 6.47M (+6.4%)
|
6.53M
est: 5.80M (+12.7%)
|
5.11M
est: 5.00M (+2.1%)
|
7.79M
est: 7.28M (+7.0%)
|
8.01M
est: 7.70M (+4.1%)
|
9.16M
est: 9.27M (-1.2%)
|
5.60M
est: 12.01M (-53.3%)
|
2.09M
est: 15.29M (-86.3%)
|
7.71M
est: 14.40M (-46.4%)
|
6.47M
est: 6.75M (-4.2%)
|
13.33M
est: 8.00M (+66.5%)
|
18.41M
est: 11.25M (+63.7%)
|
21.75M
est: 15.41M (+41.1%)
|
31.52M
est: 19.73M (+59.8%)
|
37.70M
est: 32.28M (+16.8%)
|
49.53M
est: 34.91M (+41.9%)
|
69.64M
est: 43.09M (+61.6%)
|
91.69M
est: 49.24M (+86.2%)
|
120.69M
est: 57.63M (+109.4%)
|
164.85M
est: 172.61M (-4.5%)
|
211.74M
203.64M – 224.26M
+22.7% YoY
|
273.36M
256.54M – 289.60M
+29.1% YoY
|
339.29M
337.39M – 341.19M
+24.1% YoY
|
424.67M
402.90M – 449.85M
+25.2% YoY
|
419.89M
398.37M – 444.79M
-1.1% YoY
|
| EBIT |
6.27M
est: 7.93M (-20.9%)
|
6.77M
est: 6.47M (+4.6%)
|
6.45M
est: 5.80M (+11.3%)
|
5.03M
est: 5.00M (+0.5%)
|
7.70M
est: 7.28M (+5.8%)
|
7.93M
est: 7.70M (+3.0%)
|
9.74M
est: 9.26M (+5.2%)
|
5.08M
est: 12.01M (-57.7%)
|
844.0K
est: 15.30M (-94.5%)
|
5.03M
est: 13.11M (-61.6%)
|
3.35M
est: 6.75M (-50.3%)
|
9.51M
est: 8.00M (+18.8%)
|
14.13M
est: 11.25M (+25.6%)
|
16.81M
est: 15.41M (+9.1%)
|
25.44M
est: 19.73M (+28.9%)
|
30.03M
est: 32.28M (-7.0%)
|
42.33M
est: 34.91M (+21.3%)
|
62.33M
est: 43.09M (+44.6%)
|
83.76M
est: 49.24M (+70.1%)
|
112.79M
est: 57.63M (+95.7%)
|
157.61M
est: 176.02M (-10.5%)
|
215.92M
207.66M – 228.69M
+22.7% YoY
|
278.76M
261.61M – 295.32M
+29.1% YoY
|
346.00M
344.06M – 347.93M
+24.1% YoY
|
433.06M
410.85M – 458.74M
+25.2% YoY
|
428.19M
406.23M – 453.58M
-1.1% YoY
|
| Net Income |
4.09M
est: 4.44M (-8.0%)
|
4.81M
est: 4.24M (+13.6%)
|
4.55M
est: 4.12M (+10.2%)
|
3.58M
est: 3.54M (+1.2%)
|
5.49M
est: 5.19M (+5.9%)
|
6.12M
est: 5.49M (+11.4%)
|
7.05M
est: 6.58M (+7.1%)
|
7.93M
est: 8.69M (-8.7%)
|
5.68M
est: 10.71M (-46.9%)
|
3.92M
est: 3.72M (+5.4%)
|
3.22M
est: 3.37M (-4.5%)
|
6.37M
est: 5.04M (+26.4%)
|
9.32M
est: 7.54M (+23.6%)
|
9.97M
est: 10.71M (-7.0%)
|
19.13M
est: 12.85M (+48.8%)
|
23.08M
est: 23.63M (-2.4%)
|
30.85M
est: 26.84M (+15.0%)
|
44.44M
est: 33.12M (+34.2%)
|
60.65M
est: 60.65M (+0.0%)
|
82.79M
est: 82.79M (+0.0%)
|
115.22M
est: 115.22M (+0.0%)
|
185.26M
143.41M – 227.10M
+60.8% YoY
|
184.45M
161.95M – 271.49M
-0.4% YoY
|
230.47M
204.90M – 259.01M
+25.0% YoY
|
318.98M
297.72M – 343.57M
+38.4% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
1.62M
est: 2.33M (-30.4%)
|
1.94M
est: 1.38M (+40.7%)
|
1.55M
est: 1.66M (-6.6%)
|
1.69M
est: 1.44M (+17.4%)
|
1.74M
est: 3.06M (-43.2%)
|
1.85M
est: 2.22M (-16.8%)
|
1.90M
est: 2.47M (-23.3%)
|
1.30M
est: 2.95M (-55.8%)
|
4.99M
est: 4.05M (+23.1%)
|
7.57M
est: 3.85M (+96.7%)
|
8.00M
est: 3.50M (+128.2%)
|
10.02M
est: 16.12M (-37.9%)
|
9.65M
est: 15.21M (-36.5%)
|
10.12M
est: 13.82M (-26.7%)
|
13.70M
est: 16.60M (-17.5%)
|
14.35M
est: 20.23M (-29.1%)
|
13.86M
est: 20.77M (-33.3%)
|
17.35M
est: 25.64M (-32.3%)
|
26.59M
est: 29.29M (-9.2%)
|
33.27M
est: 34.29M (-3.0%)
|
40.02M
est: 42.37M (-5.5%)
|
51.95M
49.96M – 55.02M
+22.6% YoY
|
67.06M
62.94M – 71.05M
+29.1% YoY
|
83.24M
82.77M – 83.71M
+24.1% YoY
|
104.18M
98.84M – 110.36M
+25.2% YoY
|
103.01M
97.73M – 109.12M
-1.1% YoY
|
| EPS |
0.04
est: 0.04 (-3.6%)
|
0.05
est: 0.05 (-4.0%)
|
0.05
est: 0.05 (-12.6%)
|
0.04
est: 0.04 (-9.1%)
|
0.06
est: 0.06 (-1.9%)
|
0.06
est: 0.07 (-9.2%)
|
0.07
est: 0.07 (-2.4%)
|
0.08
est: 0.08 (-1.0%)
|
0.06
est: 0.05 (+6.5%)
|
0.04
est: 0.04 (+10.3%)
|
0.03
est: 0.03 (+0.3%)
|
0.06
est: 0.06 (+12.1%)
|
0.09
est: 0.10 (-4.2%)
|
0.10
est: 0.13 (-24.3%)
|
0.18
est: 0.17 (+4.0%)
|
0.22
est: 0.23 (-5.0%)
|
0.30
est: 0.30 (-0.5%)
|
0.43
est: 0.43 (-0.3%)
|
0.58
est: 0.56 (+3.0%)
|
0.79
est: 0.76 (+4.2%)
|
1.10
est: 1.09 (+1.0%)
|
1.50
1.37 – 2.17
+37.9% YoY
|
1.81
1.55 – 2.59
+20.4% YoY
|
2.27
1.96 – 2.48
+25.5% YoY
|
3.05
2.84 – 3.28
+34.3% YoY
|
—
— – —
-100.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-28 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-27 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-25 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-22 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-15 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-05 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-01 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-15 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
243.85M
OE per share TTM
2.33
Owner's Yield
1.76%
Maintenance CapEx ratio
0.48%
Maint CapEx / Avg PPE
2.1%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
2.00M
Shares Outstanding
104.47M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Malte Westerhoff | GM of Europe & Global Chief Technology Officer | 3M | — |
| Sean Michael Lambright | Global Head of Sales - Visage Imaging Inc | 1M | male |
| Sam Aaron Hupert | Co-Founder, Chief Executive Officer, MD & Executive Director | 1M | — |
| Clayton James Hatch | Head of Business Operations & Head of Investor Relations | 546.0K | male |
| Brad Levin | GM of North America & Global Head of Marketing | 394.0K | male |
| Anthony Barry Hall | Co-Founder, Technology Director & Executive Director | 314.6K | male |
| Danny English | Chief Financial Officer & Company Sec. | 84.7K | female |
| Sharni L. Redenbach | People & Culture Director | — | female |
| Teresa Gschwind | Global Head of Customer Service of Visage Imaging Inc. | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PME.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
